U.S. House · 117th Congress · H.R. 5463
Drug Pricing Transparency and Accountability Act
To increase reporting requirements and transparency requirements in the 340B Drug Pricing Program, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Matthew M. Rosendale, Sr.R-MT-AL
- Introduced
- September 30, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.